ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Akston Biosciences, Seppic Ink Commercial Supply Agreement
July 30, 2021Akston Biosciences, a developer of new classes of biologic therapeutics, has entered a commercial agreement with Seppic S.A., a supplier of specialty healthcare ingredients, for the supply of adjuvant for use in Akston’s COVID-19 Fc fusion protein ... -
Akston Biosciences to Supply Seppic’s Adjuvant to Create Shelf-Stable COVID-19 Vaccine
July 22, 2021announced a commercial agreement with Akston Biosciences Corporation Seppic S.A., a supplier of specialty healthcare ingredients, for the supply of adjuvant for use in Akston’s COVID-19 Fc fusion protein vaccine candidate, AKS-452.
Pharma Sources Insight January 2025
